{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:11:33Z","timestamp":1784999493827,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An estimated 296 million individuals live with chronic hepatitis B worldwide, most have not been diagnosed and remain at risk of liver disease and cancer. People with hepatitis B often face discrimination that denies them employment or education opportunities, results in unfair treatment at work or in school, limits their ability to emigrate to certain countries, and in some cases prohibits them from serving in the military. Discrimination specific to hepatitis B has not been widely documented within the literature. This study aims to investigate and describe hepatitis B related discrimination, document discrimination occurring around the globe, and provide initial recommendations for addressing discrimination using key informant interviews.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Purposive and snowball sampling were used to identify potential key informants for qualitative interview. Key informants identified as community health leaders, public health scientists, doctors, and researchers, many of whom were also living with hepatitis B. Using a semi-structured guide, participants were asked to describe their experience and any challenges for people living with hepatitis B including marginalization and its\u2019 consequences. A codebook was used to guide the organization of data for analysis, and all transcripts <jats:italic>N<\/jats:italic>\u2009=\u200917 were double coded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overarching themes identified from interviews demonstrate explicit experiences with discrimination of those directly affected, the psychological responses, and the negative health outcomes associated with the unvirtuous cycle of discrimination. All key informants reported on the substantial quality of life implications and often poorer health outcomes resulting from hepatitis B discrimination. Participants also identified the significant impact of hepatitis B discrimination occurring within a range of education-based services across several countries as well as military exclusion or removal if individuals are found to have hepatitis B.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data demonstrate that hepatitis B discrimination has a significant impact. Discrimination can occur at various points in life from education, to seeking employment, to marriage, to restrictions on entry, travel and stay in other countries. This study demonstrates the impact of discrimination and the need for future research that can lead to policy change and protections for people living with and impacted by hepatitis B.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12939-022-01677-6","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:06:20Z","timestamp":1654002380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The unvirtuous cycle of discrimination affecting people with hepatitis B: a multi-country qualitative assessment of key-informant perspectives"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-2105","authenticated-orcid":false,"given":"Catherine","family":"Freeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Mendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chari","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"1677_CR1","volume-title":"Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021.\u00a0","author":"WHO","year":"2021","unstructured":"WHO. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021.\u00a0 2021. Vol 53."},{"key":"1677_CR2","doi-asserted-by":"publisher","unstructured":"Polaris Observatory Collaborators D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. lancet Gastroenterol Hepatol. 2018;3(6):383\u2013403. https:\/\/doi.org\/10.1016\/S2468-1253(18)30056-6","DOI":"10.1016\/S2468-1253(18)30056-6"},{"issue":"3","key":"1677_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"ASF Lok","year":"2009","unstructured":"Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology. 2009;50(3):661\u20132. https:\/\/doi.org\/10.1002\/hep.23190.","journal-title":"Hepatology"},{"key":"1677_CR4","doi-asserted-by":"publisher","unstructured":"Van Le T, Vu TTM, Mai HT, et al. Social determinants of stigma and discrimination in vietnamese patients with chronic hepatitis B. Int J Environ Res Public Health. 2019;16(3). https:\/\/doi.org\/10.3390\/ijerph16030398","DOI":"10.3390\/ijerph16030398"},{"issue":"1","key":"1677_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-017-0637-4","volume":"16","author":"J Wallace","year":"2017","unstructured":"Wallace J, Pitts M, Liu C, et al. More than a virus: A qualitative study of the social implications of hepatitis B infection in China. Int J Equity Health. 2017;16(1):1\u20137. https:\/\/doi.org\/10.1186\/s12939-017-0637-4.","journal-title":"Int J Equity Health"},{"issue":"5","key":"1677_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12050515","volume":"12","author":"T Tu","year":"2020","unstructured":"Tu T, Block JM, Wang S, Cohen C, Douglas MW. The lived experience of chronic hepatitis B: A broader view of its impacts and why we need a cure. Viruses. 2020;12(5):1\u201320. https:\/\/doi.org\/10.3390\/v12050515.","journal-title":"Viruses"},{"key":"1677_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/wellcomeopenres.14273.2","volume":"3","author":"J Mokaya","year":"2018","unstructured":"Mokaya J, McNaughton AL, Burbridge L, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review [version 2; referees: 2 approved]. Wellcome Open Res. 2018;3:1\u201330. https:\/\/doi.org\/10.12688\/wellcomeopenres.14273.2.","journal-title":"Wellcome Open Res"},{"issue":"3","key":"1677_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1467-9566.2009.01161.x","volume":"31","author":"G Scambler","year":"2009","unstructured":"Scambler G. Health-related stigma. Sociol Heal Illn. 2009;31(3):441\u201355. https:\/\/doi.org\/10.1111\/j.1467-9566.2009.01161.x.","journal-title":"Sociol Heal Illn"},{"issue":"9796","key":"1677_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(11)61460-8","volume":"378","author":"T Yang","year":"2011","unstructured":"Yang T, Wu MC. Discrimination against hepatitis B carriers in China. Lancet. 2011;378(9796):1059. https:\/\/doi.org\/10.1016\/S0140-6736(11)61460-8.","journal-title":"Lancet"},{"issue":"4","key":"1677_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0195455","volume":"13","author":"B Han","year":"2018","unstructured":"Han B, Yuan Q, Shi Y, et al. The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China. PLoS ONE. 2018;13(4):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0195455.","journal-title":"PLoS ONE"},{"key":"1677_CR11","unstructured":"Department of State U. China (Includes Tibet, Hong Kong, and Macau) 2015 Human Rights Report Executive Summary. 2015. https:\/\/www.state.gov\/documents\/organization\/252967.pdf."},{"issue":"9990","key":"1677_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(15)61276-4","volume":"386","author":"Q Kan","year":"2015","unstructured":"Kan Q, Wen J, Xue R. Discrimination against people with hepatitis B in China. Lancet. 2015;386(9990):245\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(15)61276-4.","journal-title":"Lancet"},{"issue":"11","key":"1677_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/liv.13168","volume":"36","author":"J Huang","year":"2016","unstructured":"Huang J, Guan ML, Balch J, et al. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing. China Liver Int. 2016;36(11):1595\u2013603. https:\/\/doi.org\/10.1111\/liv.13168.","journal-title":"China Liver Int"},{"key":"1677_CR14","doi-asserted-by":"publisher","unstructured":"Moraras K, Block J, Shiroma N, Cannizzo A, Cohen C. Protecting the Rights of Health Care Students Living With Hepatitis B Under the Americans With Disabilities Act. Public Health Rep. 2020;135(1_suppl):13S-18S. https:\/\/doi.org\/10.1177\/0033354920921252","DOI":"10.1177\/0033354920921252"},{"key":"1677_CR15","first-page":"20","volume-title":"Global partnership for action to eliminate all forms of HIV-related stigma and discrimination.","author":"UNAIDS","year":"2018","unstructured":"UNAIDS. Global partnership for action to eliminate all forms of HIV-related stigma and discrimination. 2018. p. 20."},{"issue":"9","key":"1677_CR16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388. https:\/\/doi.org\/10.1177\/1049732305276687.","journal-title":"Qual Health Res"},{"key":"1677_CR17","volume-title":"The Discovery of Grounded Theory;Strategies for Qualitative Research","author":"G Bg","year":"1967","unstructured":"Bg G, Al S, Strutzel E. The Discovery of Grounded Theory;Strategies for Qualitative Research. Chicago: Illinois; 1967."},{"issue":"8","key":"1677_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7748\/ns.24.19.64.s57","volume":"57","author":"P Corrigan","year":"2012","unstructured":"Corrigan P, Rao D. On the self-stigma of mental illness: stages, disclosure, and strategies for change. Can J Psychiatry. 2012;57(8):464\u20139. https:\/\/doi.org\/10.7748\/ns.24.19.64.s57.","journal-title":"Can J Psychiatry"},{"key":"1677_CR19","unstructured":"UN AIDS. Agenda for Zero Discrimination in Health-Care Settings. 2017:283. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2017ZeroDiscriminationHealthCare.pdf."},{"key":"1677_CR20","doi-asserted-by":"publisher","unstructured":"Freeland C, Bodor S, Perera U, Cohen C. Barriers to hepatitis B screening and prevention for African immigrant populations in the United States: A qualitative study. Viruses. 2020;12(3). https:\/\/doi.org\/10.3390\/v12030305","DOI":"10.3390\/v12030305"},{"key":"1677_CR21","doi-asserted-by":"publisher","unstructured":"Freeland C, Huynh T, Vu N, Nguyen T, Cohen C. for Vietnamese Nail Salon Workers in the City of Philadelphia and Some of Its Environs. 2021;46(3):502\u2013508. https:\/\/doi.org\/10.1007\/s10900-020-00878-w.Understanding","DOI":"10.1007\/s10900-020-00878-w.Understanding"},{"issue":"1","key":"1677_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-12-601","volume":"12","author":"R Mohamed","year":"2012","unstructured":"Mohamed R, Ng CJ, Tong WT, Abidin SZ, Wong LP, Low WY. Knowledge, attitudes and practices among people with chronic hepatitis B attending a hepatology clinic in Malaysia: A cross sectional study. BMC Public Health. 2012;12(1):1. https:\/\/doi.org\/10.1186\/1471-2458-12-601.","journal-title":"BMC Public Health"},{"key":"1677_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/sga.0000000000000335","volume":"373","author":"Y-F Liaw","year":"2009","unstructured":"Liaw Y-F, Chia-Ming C. Hepatitis B virus infection. Lancet. 2009;373:582\u201392. https:\/\/doi.org\/10.1097\/sga.0000000000000335.","journal-title":"Lancet"},{"issue":"12","key":"1677_CR24","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"30","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.116.","journal-title":"Vaccine"},{"issue":"5","key":"1677_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a021410","volume":"5","author":"JH MacLachlan","year":"2015","unstructured":"MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):1\u201312. https:\/\/doi.org\/10.1101\/cshperspect.a021410.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1677_CR26","unstructured":"Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2019.; 2019. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/324797\/WHO-CDS-HIV-19.7-eng.pdf?ua=1. Accessed July 21, 2019."}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-022-01677-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-022-01677-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-022-01677-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T13:14:59Z","timestamp":1654002899000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-022-01677-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1677"],"URL":"https:\/\/doi.org\/10.1186\/s12939-022-01677-6","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"28 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Heartland Institutional Review Board with verbal consent obtained and recorded by all study participants prior to each interview. This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments and comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Hepatitis B Foundation receives independent grants for public health programming, outreach and education from: Gilead Sciences, VBI Vaccines, Dynavax Technologies, Arbutus Biopharma, Janssen, GSK, BMS, and Antios. Chari Cohen serves on community advisory boards for Gilead Sciences and GSK. Lindsay Mendola is currently employed with GSK. VC, JW, and CF have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}